ISB to support Healing Hastha in mainstreaming Ayurveda and Naturopathy

Hyderabad: To provide impetus to the practice of Ayurveda and Naturopathy and bring it to the mainstream of treatment, Hyderabad-based Healing Hastha, an Ayurveda & Naturopathy-focused company has partnered with the Centre for Business Markets at the Indian School of Business (ISB-CBM).

Speaking on the potential of these systems of treatment and the nature of engagement with Healing Hastha, Professor D.V.R. Seshadri, Director, ISB-CBM said, “Ayurveda and Naturopathy offer tremendous potential to enhance human well-being, without side effects, especially in the case of chronic ailments and lifestyle disorders. At ISB-CBM, we excel in taking up marketing challenges being faced by organisations, and through our research-based consulting, help our clients to succeed in their markets. We see our relationship with Dr. Masthan Yadav, the founder of Healing Hastha as furthering both these objectives.”

Dr. Masthan Yadav, said, “It is a pleasure for our company, Healing Hastha, to partner with ISB-CBM, to find ways to mainstream our various Ayurvedic and Naturopathic products, and thereby work towards alleviating human suffering and enhancing the quality of human life. I am particularly happy to see that through this partnership, ISB-CBM is encouraging Indian medicinal systems to come to the forefront. Unfortunately, despite their huge potential, historically, they had not received the attention they deserve.”

These systems of indigenous medicinal systems focus on the belief that if the patient takes responsibility for their health, the body has capacity to heal itself. Consequently, rather than become a life-long patient of treatment, these streams provide holistic care and thus help prevent recurring health problems. With this collaboration, Healing Hastha and ISB-CBM, plan to work on creating synergies, thereby improving people’s lives, while strengthening the healthcare ecosystem in India by offering a viable and efficacious healthcare alternative.

** For Favour of Publication.**

Comments are closed.